Novel Approaches in Cancer & Tumor

Immunotherapy encompasses several different treatment approaches, each of which has a distinct mechanism of action, and all of which are designed to boost or restore immune function in some manner.  This includes: Monoclonal antibodies, Immune checkpoint inhibitors, Therapeutic Cancer vaccines, cytokines, and other non-specific immunotherapies.

Focusing on the immune enhancing properties of histamine, a biogenic amine. Histamine inhibits ROS formation in MO via H2-receptors; thereby, histamine protects NK cells from MO-mediated inhibition and synergizes with IL-2 and IFN-alpha to induce killing of NK cell-sensitive human tumor cells in vitro.

    Related Conference of Novel Approaches in Cancer & Tumor

    March 04-05, 2019

    10th Molecular Immunology & Immunogenetics Congress

    Barcelona, Spain
    March 18-19, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    March 18-19, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    April 15-18, 2019

    Annual Immunology Conference 2019

    Savannah, USA
    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 24-25, 2019

    11th World Congress and Expo on Immunology

    Vancouver, Canada
    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    October 21-22, 2019

    12th Annual Congress on Immunology & Immunogenetics

    Rome, Italy
    November 22-23, 2019 |

    World Conference on Vaccine and Immunology

    Dubai, UAE

    Novel Approaches in Cancer & Tumor Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in